相似文献
1
Granulocyte transfusions in the management of invasive fungal infections.
Br J Haematol. 2017 May;177(3):357-374. doi: 10.1111/bjh.14597. Epub 2017 Mar 14.
2
Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction.
Cochrane Database Syst Rev. 2015 Jun 29;2015(6):CD005341. doi: 10.1002/14651858.CD005341.pub3.
3
Granulocyte transfusion therapy: update on potential clinical applications.
Curr Opin Hematol. 2001 May;8(3):161-4. doi: 10.1097/00062752-200105000-00006.
4
Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction.
Cochrane Database Syst Rev. 2009 Jan 21(1):CD005341. doi: 10.1002/14651858.CD005341.pub2.
5
Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction.
Cochrane Database Syst Rev. 2016 Apr 29;4(4):CD005339. doi: 10.1002/14651858.CD005339.pub2.
6
Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction.
Cochrane Database Syst Rev. 2005 Jul 20(3):CD005339. doi: 10.1002/14651858.CD005339.
7
Granulocyte transfusions: Current science and perspectives.
Semin Hematol. 2019 Oct;56(4):241-247. doi: 10.1053/j.seminhematol.2019.11.002. Epub 2019 Nov 8.
8
Granulocyte transfusion in the G-CSF era.
Int J Hematol. 2002 Aug;76 Suppl 2:77-80. doi: 10.1007/BF03165092.
9
[Granulocyte transfusion – when and how should it be used?].
Lakartidningen. 2018 Mar 20;115:EXUU.
10
Granulocyte transfusions in the management of neutropenic fever: A pediatric perspective.
Transfus Apher Sci. 2018 Feb;57(1):16-19. doi: 10.1016/j.transci.2018.02.009. Epub 2018 Feb 20.
引用本文的文献
1
Prognostic Factors for 28-Day Mortality in Pediatric Patients with Acute Leukemia and Candidemia Following Intensive Chemotherapy: A Retrospective Study.
Hematol Rep. 2025 Jul 30;17(4):38. doi: 10.3390/hematolrep17040038.
2
Interplay between fungal infections and autoimmunity: mechanisms and therapeutic perspectives.
EMBO Mol Med. 2025 Jun 17. doi: 10.1038/s44321-025-00262-y.
3
Severe dual fungal infection after bispecific antibody therapy: A case of invasive aspergillosis and mucormycosis in immunocompromised patient.
IDCases. 2024 Dec 22;39:e02140. doi: 10.1016/j.idcr.2024.e02140. eCollection 2025.
4
Mucormycosis.
Infect Dis Clin North Am. 2025 Mar;39(1):121-144. doi: 10.1016/j.idc.2024.11.008. Epub 2024 Dec 4.
5
Clinical characteristics and risk factors of acute lymphoblastic leukemia in children with severe infection during maintenance treatment.
Cancer Med. 2023 Oct;12(19):19372-19382. doi: 10.1002/cam4.6495. Epub 2023 Sep 28.
6
Exploiting antifungal immunity in the clinical context.
Semin Immunol. 2023 May;67:101752. doi: 10.1016/j.smim.2023.101752. Epub 2023 Mar 29.
7
Novel Insights into Fungal Infections Prophylaxis and Treatment in Pediatric Patients with Cancer.
Antibiotics (Basel). 2022 Sep 27;11(10):1316. doi: 10.3390/antibiotics11101316.
8
Case report: A () severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcoma.
Front Oncol. 2022 Sep 15;12:970188. doi: 10.3389/fonc.2022.970188. eCollection 2022.
9
Primitive genotypic characteristics in umbilical cord neutrophils identified by single-cell transcriptome profiling and functional prediction.
Front Immunol. 2022 Aug 29;13:970909. doi: 10.3389/fimmu.2022.970909. eCollection 2022.
10
Risk stratification by 30-day prognostic factors of clinical outcomes after granulocyte transfusion in acute myeloid leukemia: A single-center retrospective study.
PLoS One. 2022 Aug 30;17(8):e0273827. doi: 10.1371/journal.pone.0273827. eCollection 2022.
本文引用的文献
1
Galactomannan, β-D-Glucan, and Polymerase Chain Reaction-Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Clin Infect Dis. 2016 Nov 15;63(10):1340-1348. doi: 10.1093/cid/ciw592. Epub 2016 Aug 27.
2
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
Clin Infect Dis. 2016 Aug 15;63(4):e1-e60. doi: 10.1093/cid/ciw326. Epub 2016 Jun 29.
3
An overview of infectious complications after allogeneic hematopoietic stem cell transplantation.
J Infect Chemother. 2016 Aug;22(8):505-14. doi: 10.1016/j.jiac.2016.05.006. Epub 2016 Jun 22.
4
Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction.
Cochrane Database Syst Rev. 2016 Apr 29;4(4):CD005339. doi: 10.1002/14651858.CD005339.pub2.
5
Therapeutic Drug Monitoring and Genotypic Screening in the Clinical Use of Voriconazole.
Curr Fungal Infect Rep. 2015 Jun;9(2):74-87. doi: 10.1007/s12281-015-0219-0. Epub 2015 Apr 16.
6
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Lancet. 2016 Feb 20;387(10020):760-9. doi: 10.1016/S0140-6736(15)01159-9. Epub 2015 Dec 10.
7
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.
Clin Infect Dis. 2016 Feb 15;62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16.
8
Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection.
Blood. 2015 Oct 29;126(18):2153-61. doi: 10.1182/blood-2015-05-645986. Epub 2015 Sep 2.
9
Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction.
Cochrane Database Syst Rev. 2015 Jun 29;2015(6):CD005341. doi: 10.1002/14651858.CD005341.pub3.
10
Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.
BMC Infect Dis. 2015 Mar 17;15:128. doi: 10.1186/s12879-015-0855-6.
Zotero 插件